MEK inhibitor

MEK inhibitor is a type of drug that inhibits the mitogen-activated protein kinase kinase (MEK). It is used in the treatment of various types of cancer, including melanoma, lung cancer, colorectal cancer, and thyroid cancer.

Mechanism of action

MEK inhibitors work by blocking the action of a protein called MEK, which is part of a pathway that helps cells to divide and survive. By inhibiting MEK, these drugs can stop cancer cells from growing and dividing.

Types of MEK inhibitors

There are several types of MEK inhibitors, including:

• Selumetinib
• Trametinib
• Cobimetinib
• Binimetinib

Each of these drugs has been approved by the Food and Drug Administration (FDA) for use in certain types of cancer.

Side effects

Like all drugs, MEK inhibitors can cause side effects. These can vary from person to person, but may include:

• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Skin rash

See also

• Cancer treatment
• Chemotherapy
• Targeted therapy

MEK inhibitor Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski